Home Compare DXCM vs MEDP
Stock Comparison · Single-driver result

DexCom vs Medpace Holdings: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Medpace carrying a narrow edge on stability. DexCom still has the edge on valuation, which keeps the comparison from looking entirely one-sided. On the market side, Medpace is in better shape — its trend is intact while DexCom's trend has broken down. That puts structure and market broadly in agreement — Medpace's lead looks more confirmed than conflicted.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

Stability still does most of the heavy lifting in this comparison.

Trajectory Similarity
0.71
Similar
Peer-set rank: #6
within DexCom, Inc.'s functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

The pair sits on a clearly comparable long-term path, though it is not a near-twin match.

Most of the shared profile comes through margin consistency and revenue growth trajectory.

Similarity drivers
margin consistencyrevenue growth trajectory
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
DXCM
DexCom, Inc.
69
Peer-Score
Signal qualityHigh
vs
MEDP
Medpace Holdings, Inc.
70
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in stability.

Dimension spread: DXCM vs MEDP Profitability 97 88 Stability 14 40 Valuation 69 57 Growth 83 91 DXCM MEDP
Gap Ranking
#1 Stability +26
#2 Valuation +12
#3 Profitability +9
#4 Growth +8
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for DXCM and MEDP Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer DXCMMEDP Relative valuation Structural strength

Medpace Holdings, Inc. still looks cheaper, even though DexCom, Inc. remains structurally stronger.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Stability
Medpace Holdings, Inc. sits higher in the group on stability, adding to the overall structural advantage.
Valuation
Both rank well on valuation, but DexCom, Inc. still sits higher.
Stability — Dominant Gap
DXCM
14
MEDP
40
Gap+26in favour of MEDP

The clearest distance comes from a steadier profile over time.

What keeps the gap from being one-sided

Absolute pricing still looks more supportive for DexCom, with a forward P/E that is 3 turns lower there.

What this means for the comparison

The main read on stability is clearer than the broader score gap.

Explore full peer positioning in AssetNext

Break down the DXCM vs MEDP comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar stability-driven comparisons

Explore how DXCM and MEDP each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.